{"id":"W2560708148","doi":"10.1016/s1470-2045(16)30632-5","title":"Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Royal Victoria Hospital; Dalhousie University","funders":"Pharmacyclics","keywords":"Rituximab; Medicine; Ibrutinib; Internal medicine; Population; Waldenstrom macroglobulinemia; Oncology; Lymphoma; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001014993,0.0002022529,0.0007796208,0.00008705579,0.00009315627,0.00002925346,0.001093122,0.0001618804,0.0002521218],"category_scores_gemma":[0.0005774178,0.000103855,0.0000337319,0.000165085,0.000392052,0.0003194936,0.0002634071,0.000203905,0.00003012881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003475532,"about_ca_system_score_gemma":0.002896732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002046026,"about_ca_topic_score_gemma":0.0001624652,"domain_scores_codex":[0.9977619,0.0002603928,0.0005112894,0.0004528933,0.000467933,0.0005456053],"domain_scores_gemma":[0.9972728,0.0006597445,0.0003463142,0.0009056244,0.000645111,0.0001703624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.794345,0.03701985,0.003163285,0.0001071745,0.0006133705,0.0001793943,0.0009003841,9.942744e-7,0.006184508,0.0009333121,0.003727429,0.1528253],"study_design_scores_gemma":[0.9372995,0.03335293,0.001855623,0.00008862187,0.0001424949,0.00005159631,0.0001229133,0.0006759244,0.001651485,0.0001313862,0.02445537,0.0001721445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927904,0.00002088051,0.00006226933,0.001513518,0.0005502639,0.00349078,0.0002195314,0.00004396584,0.001308415],"genre_scores_gemma":[0.9946985,0.00005397912,0.003001607,0.0005005107,0.0008683773,0.0002533087,0.0001866283,0.00004327385,0.0003938499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1526531,"threshold_uncertainty_score":0.9088395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1097531342863321,"score_gpt":0.454956165901559,"score_spread":0.3452030316152269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}